Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $9,612,000 | -34.6% | 903,400 | -50.0% | 100.00% | +12.7% |
| ZY | Exit | ZYMERGEN INC | $0 | – | -1,513,727 | – | -11.24% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | New | RECURSION PHARMACEUTICALS INcl a | $14,707,000 | – | 1,806,800 | – | 88.76% | – |
| ZY | New | ZYMERGEN INC | $1,862,000 | – | 1,513,727 | – | 11.24% | – |